Gorka Fius
Directeur Général chez Dreavent, Inc.
Profil
Gorka Fius founded Dreamers Factory Innovacion Outpost SL in 2019, where he worked as Founding Partner from 2019 to 2021 and Dreavent, Inc. in 2019, where he is working as Chief Executive Officer from 2019.
Mr. Fius also currently works at Chimeron Bio Corp., as Board of Director from 2022.
Mr. Fius also formerly worked at Elicio Therapeutics, Inc. (Old), as Board of Director from 2022 to 2023 and Artá Capital SGEIC SA, as Advisor from 2017 to 2018.
Mr. Fius received his graduate degree from the University of Navarra.
Postes actifs de Gorka Fius
| Sociétés | Poste | Début |
|---|---|---|
Dreavent, Inc.
 Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | Directeur Général | 01/11/2019 |
Chimeron Bio Corp.
 Chimeron Bio Corp. Medical SpecialtiesHealth Technology Chimeron Bio Corp. is a biotechnology company based in the USA that is focused on developing a pipeline of products in oncology, rare genetic disorders, and infectious diseases using its proprietary chaesar™ platform. The American company is researching self-amplifying RNA (sRNA) to develop novel RNA drugs and vaccines for various diseases. Chimeron Bio is combining a first-in-class platform and the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics. The company was founded by Jolly Mazumdar, and the CEO is Kevin J. Heyeck. | Directeur/Membre du Conseil | 01/11/2022 |
Anciens postes connus de Gorka Fius
| Sociétés | Poste | Fin |
|---|---|---|
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/07/2023 |
Dreamers Factory Innovacion Outpost SL
 Dreamers Factory Innovacion Outpost SL Investment ManagersFinance Dreamers Factory Innovacion Outpost SL (Dreamers Factory) is a venture capital firm founded in 2019 by Jose Antonio Borge, Eneko Knörr and Gorka Fius. The firm is headquartered in Spain with an additional office in the US. | Fondateur | 01/03/2021 |
Artá Capital SGEIC SA
 Artá Capital SGEIC SA Investment ManagersFinance Artá Capital SGEIC SA (Artá Capital) is a private equity arm of Artá Partners SA founded in 2007. The firm is headquartered in Madrid, Spain. | Consultant / Advisor | 01/05/2018 |
Formation de Gorka Fius
| University of Navarra | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Dreamers Factory Innovacion Outpost SL
Dreamers Factory Innovacion Outpost SL Investment ManagersFinance Dreamers Factory Innovacion Outpost SL (Dreamers Factory) is a venture capital firm founded in 2019 by Jose Antonio Borge, Eneko Knörr and Gorka Fius. The firm is headquartered in Spain with an additional office in the US. | Finance |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Chimeron Bio Corp. is a biotechnology company based in the USA that is focused on developing a pipeline of products in oncology, rare genetic disorders, and infectious diseases using its proprietary chaesar™ platform. The American company is researching self-amplifying RNA (sRNA) to develop novel RNA drugs and vaccines for various diseases. Chimeron Bio is combining a first-in-class platform and the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics. The company was founded by Jolly Mazumdar, and the CEO is Kevin J. Heyeck. | Health Technology |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
Artá Capital SGEIC SA
Artá Capital SGEIC SA Investment ManagersFinance Artá Capital SGEIC SA (Artá Capital) is a private equity arm of Artá Partners SA founded in 2007. The firm is headquartered in Madrid, Spain. | Finance |
